Patent Publication Number: US-2020295269-A1

Title: Heterocyclic compound and organic light-emitting device including the same

Description:
CROSS-REFERENCE TO RELATED APPLICATION 
     This application claims the benefit of Korean Patent Application No. 10-2019-0027637, filed on Mar. 11, 2019, in the Korean Intellectual Property Office, the disclosure of which is incorporated herein in its entirety by reference. 
     BACKGROUND 
     1. Field 
     One or more embodiments relate to a heterocyclic compound and an organic light-emitting device including the same. 
     2. Description of the Related Art 
     Organic light-emitting devices are self-emission devices that produce full-color images, and also have wide viewing angles, high contrast ratios, short response times, and excellent characteristics in terms of brightness, driving voltage, and response speed, compared to devices in the art. 
     An example of such organic light-emitting devices may include a first electrode disposed on a substrate, and a hole transport region, an emission layer, an electron transport region, and a second electrode, which are sequentially disposed on the first electrode. Holes provided from the first electrode may move toward the emission layer through the hole transport region, and electrons provided from the second electrode may move toward the emission layer through the electron transport region. Carriers, such as holes and electrons, recombine in the emission layer to produce excitons. These excitons transit from an excited state to a ground state, thereby generating light. 
     SUMMARY 
     Aspects of the present disclosure provide a heterocyclic compound and an organic light-emitting device including the same. 
     Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments. 
     An aspect of the present disclosure provides a heterocyclic compound represented by Formula 1: 
     
       
         
         
             
             
         
       
     
     In Formula 1, 
     Ar 1  may be selected from a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), and —N(Q 1 )(Q 2 ), 
     b1 may be an integer from 1 to 5, 
     when b1 is 2, 3, 4, or 5, two, three, four, or five Ar 1 (s) may be identical to or different from each other, 
     D 1  may be a group represented by Formula 2, 
     n may be an integer from 2 to 5, and 
     when n is 2, 3, 4, or 5, two, three, four, or five D 1 (s) may be identical to or different from each other: 
     
       
         
         
             
             
         
       
     
     In Formula 2, 
     X 1  may be selected from a single bond, C(R 5 )(R 6 ), Si(R 5 )(R 6 ), N(R 5 ), O, and S, 
     A 1  and A 2  may each independently be a C 5 -C 60  carbocyclic group or a C 1 -C 60  heterocyclic group, 
     L 1  may be selected from a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, 
     a 1  may be 0 or 1, 
     * indicates a binding site to a neighboring atom, 
     in Formulae 1 and 2, 
     R 1  to R 6  may each independently be selected from hydrogen, deuterium, —F —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60  alkyl group, a substituted or unsubstituted C 2 -C 60  alkenyl group, a substituted or unsubstituted C 2 -C 60  alkynyl group, a substituted or unsubstituted C 1 -C 60  alkoxy group, a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O) 2 (Q 1 ), and —P(═O)(Q 1 )(Q 2 ), 
     c1 may be an integer from 0 to 3, 
     c2 may be an integer from 0 to 4, 
     c3 and c4 may each independently be an integer from 1 to 5, 
     at least one substituent of the substituted C 3 -C 10  cycloalkylene group, the substituted C 1 -C 10  heterocycloalkylene group, the substituted C 3 -C 10  cycloalkenylene group, the substituted C 1 -C 10  heterocycloalkenylene group, the substituted C 6 -C 60  arylene group, the substituted C 1 -C 60  heteroarylene group, the substituted divalent non-aromatic condensed polycyclic group, the substituted divalent non-aromatic condensed heteropolycyclic group, the substituted C 1 -C 60  alkyl group, the substituted C 2 -C 60  alkenyl group, the substituted C 2 -C 60  alkynyl group, the substituted C 1 -C 60  alkoxy group, the substituted C 3 -C 10  cycloalkyl group, the substituted C 1 -C 10  heterocycloalkyl group, the substituted C 3 -C 10  cycloalkenyl group, the substituted C 1 -C 10  heterocycloalkenyl group, the substituted C 6 -C 60  aryl group, the substituted C 6 -C 60  aryloxy group, the substituted C 6 -C 60  arylthio group, the substituted C 1 -C 60  heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group may be selected from: 
     deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, and a C 1 -C 60  alkoxy group; 
     a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, and a C 1 -C 60  alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), and —P(═O)(Q 11 )(Q 12 ); 
     a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group; 
     a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, a C 1 -C 60  alkoxy group, a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), and —P(═O)(Q 21 )(Q 22 ); and 
     —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), and 
     Q 1  to Q 3 , Q 11  to Q 13 , Q 21  to Q 23 , and Q 31  to Q 33  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, a C 1 -C 60  alkoxy group, a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group. 
     Another aspect of the present disclosure provides an organic light-emitting device including: a first electrode; a second electrode facing the first electrode; an organic layer between the first electrode and the second electrode and including an emission layer, and at least one of the heterocyclic compounds represented by Formula 1. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
       These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings in which: 
         FIG. 1  is a schematic view of an organic light-emitting device according to an embodiment; 
         FIG. 2  is a schematic view of an organic light-emitting device according to another embodiment; 
         FIG. 3  is a schematic view of an organic light-emitting device according to another embodiment; and 
         FIG. 4  is a schematic view of an organic light-emitting device according to another embodiment. 
     
    
    
     DETAILED DESCRIPTION 
     Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items. Expressions such as “at least one of,” when preceding a list of elements, modify the entire list of elements and do not modify the individual elements of the list. 
     An aspect of the present disclosure provides a heterocyclic compound represented by Formula 1: 
     
       
         
         
             
             
         
       
     
     Ar 1  in Formula 1 may be selected from a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), and —N(Q 1 )(Q 2 ). 
     In one embodiment, Ar 1  in Formula 1 may be selected from: 
     a pyrrolyl group, a thiophenyl group, a furanyl group, a silolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzothiazolyl group, a benzosilolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a benzonaphthofuranyl group, a benzonaphthothiophenyl group, a benzonaphtho silolyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an oxazolopyridinyl group, a thiazolopyridinyl group, a benzonaphthyridinyl group, a fluorenyl group, an azafluorenyl group, an azaspiro-bifluorenyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azadibenzosilolyl group, a diazafluorenyl group, a diazaspiro-bifluorenyl group, a diazacarbazolyl group, a diazadibenzofuranyl group, a diazadibenzothiophenyl group, and a diazadibenzosilolyl group; 
     a pyrrolyl group, a thiophenyl group, a furanyl group, a silolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzothiazolyl group, a benzosilolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a benzonaphthofuranyl group, a benzonaphthothiophenyl group, a benzonaphtho silolyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an oxazolopyridinyl group, a thiazolopyridinyl group, a benzonaphthyridinyl group, a fluorenyl group, an azafluorenyl group, an azaspiro-bifluorenyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azadibenzosilolyl group, a diazafluorenyl group, a diazaspiro-bifluorenyl group, a diazacarbazolyl group, a diazadibenzofuranyl group, a diazadibenzothiophenyl group, and a diazadibenzosilolyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-cyclopentane-fluorenyl group, a spiro-cyclohexane-fluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a pyrenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, a silolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an indolyl group, an isoindolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a benzothiazolyl group, a benzosilolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a dibenzosilolyl group, a benzonaphthofuranyl group, a benzonaphthothiophenyl group, a benzonaphtho silolyl group, a carbazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an oxazolopyridinyl group, a thiazolopyridinyl group, a benzonaphthyridinyl group, an azafluorenyl group, an azaspiro-bifluorenyl group, an azacarbazolyl group, an azadibenzofuranyl group, an azadibenzothiophenyl group, an azadibenzosilolyl group, a diazafluorenyl group, a diazaspiro-bifluorenyl group, a diazacarbazolyl group, a diazadibenzofuranyl group, a diazadibenzothiophenyl group, a diazadibenzosilolyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ); and 
     —Si(Q 1 )(Q 2 )(Q 3 ) and —N(Q 1 )(Q 2 ), and 
     Q 1  to Q 3  and Q 31  to Q 33  may each independently be selected from hydrogen, deuterium, a C 1 -C 60  alkyl group, a C 1 -C 60  alkoxy group, a C 6 -C 60  aryl group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group. 
     For example, Ar 1  in Formula 1 may be selected from: 
     a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, an azacarbazolyl group, and a diazacarbazolyl group; 
     a carbazolyl group, a dibenzofuranyl group, a dibenzothiophenyl group, an azacarbazolyl group, and a diazacarbazolyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), and —B(Q 31 )(Q 32 ); and 
     —Si(Q 1 )(Q 2 )(Q 3 ) and —N(Q 1 )(Q 2 ). 
     In one or more embodiments, Ar 1  in Formula 1 may be selected from groups represented by Formulae 5-1 to 5-9: 
     
       
         
         
             
             
         
       
     
     In Formulae 5-1 to 5-9, 
     Y 31  may be C(Z 33 )(Z 34 ), Si(Z 33 )(Z 34 ), N(Z 33 ), O, or S, 
     Z 31  to Z 34  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), and —B(Q 31 )(Q 32 ), 
     e3 may be an integer from 1 to 3, 
     e4 may be an integer from 1 to 4, 
     Q 1  to Q 3  and Q 31  to Q 33  may each independently be selected from hydrogen, deuterium, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a C 6 -C 20  aryl group, a C 1 -C 20  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, and 
     * indicates a binding site to a neighboring atom. 
     In one embodiment, Q 1  to Q 3  in Formulae 5-8 and 5-9 may each independently be a phenyl group. 
     In one or more embodiments, Ar 1  in Formula 1 may be selected from groups represented by Formulae 6-1 to 6-35: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     In Formulae 6-1 to 6-35, 
     Ph indicates a phenyl group, t-Bu indicates a tert-butyl group, and Cz indicates a carbazolyl group, and 
     * indicates a binding site to a neighboring atom. 
     In Formulae 6-5 to 6-12, 6-17 to 6-24, and 6-26 to 6-31, a position at which a substituent, e.g., —Si(Ph) 3 , a tert-butyl group, or a carbazolyl group, is substituted in a benzene ring is not particularly limited, and an appropriate position for achieving the purpose of the molecular design may be selected. For example, in order to increase the steric hindrance of the compound represented by Formula 1, Ar 1  may be selected from groups represented by the following formulae, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
     
     In Formula 1, b1 indicates the number of Ar 1 (s), wherein b1 may be an integer from 1 to 5. When b1 is two, three, four, or five, two, three, four, or five Ar 1 (s) may be identical to or different from each other. 
     In Formula 1, D 1  may be a group represented by Formula 2. 
     In Formula 1, n indicates the number of D 1 (s), wherein n may be an integer from 2 to 5. When n is two, three, four, or five, two, three, four, or five D 1 (s) may be identical to or different from each other. 
     In one embodiment, in Formula 1, n may be two, two D 1 (s) may be identical to or different from each other. 
     
       
         
         
             
             
         
       
     
     In Formula 2, X 1  may be selected from a single bond, C(R 5 )(R 6 ), Si(R 5 )(R 6 ), N(R 5 ), O, and S. 
     For example, X 1  may be selected from a single bond, C(R 5 )(R 6 ), O, and S. 
     In Formula 2, A 1  and A 2  may each independently be a C 5 -C 60  carbocyclic group or a C 1 -C 60  heterocyclic group. A 1  and A 2  may each independently be condensed with a ring represented by 
     
       
         
         
             
             
         
       
     
     In one embodiment, A 1  and A 2  in Formula 2 may each independently be selected from a benzene ring, a naphthalene ring, an anthracene ring, a phenanthrene ring, a triphenylene ring, a fluorene ring, a carbazole ring, a dibenzofuran ring, a dibenzothiophene ring, a dibenzosilole ring, and a 9,10-dihydroacridine ring. 
     For example, A 1  and A 2  in Formula 2 may each independently be selected from a benzene ring, a naphthalene ring, a fluorene ring, a carbazole ring, a dibenzofuran ring, a dibenzothiophene ring, and a dibenzosilole ring. 
     For example, A 1  and A 2  in Formula 2 may each independently be selected from a benzene ring and a naphthalene ring. 
     In Formula 2, L 1  may be selected from a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group. 
     In Formula 2, a1 may be 0 or 1, wherein, when a1 is 0, *-(L 1 ) a1 -*′ may be a single bond. 
     In one embodiment, a1 in Formula 2 may be 0. 
     In one embodiment, D 1  in Formula 1 may be selected from: 
     a carbazolyl group, a 9,10-dihydroacridinyl group, a phenoxazinyl group, a phenothiazinyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group; and 
     a carbazolyl group, a 9,10-dihydroacridinyl group, a phenoxazinyl group, a phenothiazinyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group. 
     In one embodiment, D 1  in Formula 1 may be a group represented by Formula 2-1: 
     
       
         
         
             
             
         
       
     
     In Formula 2-1, X 1 , R 3 , R 4 , c3, and c4 are each independently the same as described above. 
     In one embodiment, D 1  in Formula 1 may be selected from groups represented by Formulae 2-2 to 2-5: 
     
       
         
         
             
             
         
       
     
     In Formulae 2-2 to 2-5, 
     R 5  and R 6  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a cyano group, a nitro group, a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a neopentyl group, a hexyl group, a phenyl group, and a biphenyl group. 
     In Formulae 1 and 2, R 1  to R 6  may each independently be selected from hydrogen, deuterium, —F —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60  alkyl group, a substituted or unsubstituted C 2 -C 60  alkenyl group, a substituted or unsubstituted C 2 -C 60  alkynyl group, a substituted or unsubstituted C 1 -C 60  alkoxy group, a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O) 2 (Q 1 ), and —P(═O)(Q 1 )(Q 2 ), 
     c1 may be an integer from 0 to 3, 
     c2 may be an integer from 0 to 4, 
     c3 and c4 may each independently be an integer from 1 to 5. 
     In one embodiment, R 1  to R 6  may each independently be selected from: 
     hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; 
     a carbazolyl group, a 9,10-dihydroacridinyl group, a phenoxazinyl group, a phenothiazinyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and 
     a carbazolyl group, a 9,10-dihydroacridinyl group, a phenoxazinyl group, a phenothiazinyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group that are each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a C 6 -C 20  aryl group, and a C 1 -C 20  heteroaryl group. 
     In one or more embodiments, R 1  to R 6  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a methyl group, an ethyl group, a propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a sec-pentyl group, a tert-pentyl group, a neopentyl group, a hexyl group, a phenyl group, and a biphenyl group. 
     In one embodiment, the heterocyclic compound may be represented by one selected from Formulae 1-1 to 1-4: 
     
       
         
         
             
             
         
       
     
     In Formulae 1-1 to 1-4, 
     D 1a  and D 1b  may each independently be the same as defined in connection with D 1 , 
     D 1a  and D 1b  may be identical to or different from each other, 
     Ar 1 , R 1 , and R 2  are the same as described above, 
     c1 may be an integer from 1 to 3, and 
     c2 may be an integer from 1 to 4. 
     In one or more embodiments, the heterocyclic compound may be represented by one selected from Formulae 1-1A to 1-1C, 1-2A to 1-2C, 1-3A to 1-3C, and 1-4A to 1-4C: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     In Formulae 1-1A to 1-1C, 1-2A to 1-2C, 1-3A to 1-3C, and 1-4A to 1-4C, 
     D 1a  and D 1b  may each independently be the same as defined in connection with D 1 , 
     D 1a  and D 1b  may be identical to or different from each other, 
     Ar 1 , R 1 , and R 2  are the same as described above, 
     c1 may be an integer from 1 to 3, and 
     c2 may be an integer from 1 to 4. 
     In one embodiment, Ar 1  in Formulae 1-1A to 1-1C, 1-2A to 1-2C, 1-3A to 1-3C, and 1-4A to 1-4C may be selected from groups represented by Formulae 6-1 to 6-35. 
     In one embodiment, D 1a  and D 1b  in Formulae 1-1A to 1-1C, 1-2A to 1-2C, 1-3A to 1-3C, and 1-4A to 1-4C may each independently be selected from: 
     a carbazolyl group, a 9,10-dihydroacridinyl group, a phenoxazinyl group, a phenothiazinyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group; and 
     a carbazolyl group, a 9,10-dihydroacridinyl group, a phenoxazinyl group, a phenothiazinyl group, a benzocarbazolyl group, and a dibenzocarbazolyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a spiro-fluorene-benzofluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a triazinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group. 
     In one or more embodiments, in Formulae 1-1A to 1-1C, 1-2A to 1-2C, 1-3A to 1-3C, and 1-4A to 1-4C, D 1a  and D 1b  may each independently be selected from groups represented by Formulae 2-2 to 2-5. 
     In one embodiment, in Formulae 1-1A to 1-1C, 1-2A to 1-2C, 1-3A to 1-3C, and 1-4A to 1-4C, each of R 1  and R 2  may be hydrogen. 
     In one embodiment, the heterocyclic compound may be represented by one selected from Formulae 1-1A, 1-1B, 1-2A, 1-2B, 1-3A, 1-3B, 1-4A, and 1-4B. In Formulae 1-1A, 1-1B, 1-2A, 1-2B, 1-3A, 1-3B, 1-4A, and 1-4B, since the Ar 1  group is substituted at an ortho position or a meta position of a biphenyl group, the Ar 1  group may relatively increase the steric hindrance between substituents in a molecule, as compared with a case where the Ar 1  group is substituted at a para position of the biphenyl group. 
     In one embodiment, the heterocyclic compound may be represented by one selected from Formulae 1-1A, 1-1B, 1-2A, 1-2B, 1-3A, 1-3B, 1-4A, and 1-4B, and Ar 1  may be selected from groups represented by Formulae 6-1 to 6-35. 
     In one embodiment, the heterocyclic compound may have a triplet energy level of 3.0 eV or more. 
     In one embodiment, the heterocyclic compound may be selected from Compounds 1 to 39: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     Since substituents D 1  and Ar 1  are substituted at a specific position of a biphenyl group, the heterocyclic compound represented by Formula 1 may have a structure in which intramolecular steric hindrance is large. 
     
       
         
         
             
             
         
       
     
     A dihedral angle between a plane P 1  including a phenyl group in which D 1  is substituted and a plane P 2  including a phenyl group in which Ar 1  is substituted may increase. Therefore, a pi conjugation system of a molecule represented by Formula 1 may become short, and the heterocyclic compound may have high triplet energy. Consequently, the heterocyclic compound represented by Formula 1 may be suitable for use as a material for an organic light-emitting device, for example, for use as a host of an emission layer. For example, the heterocyclic compound represented by Formula 1 may be suitable for use as a blue host used together with a blue dopant. 
     In addition, since the heterocyclic compound represented by Formula 1 includes two or more electron donor substituents represented by D 1 , hole injection capability is improved, which may be suitable to energy transfer. 
     Furthermore, the energy level and molecular polarity may be easily adjusted by introducing substituents having various characteristics into the heterocyclic compound. 
     Therefore, an electronic device, for example, an organic light-emitting device, which includes the heterocyclic compound, may have a low driving voltage, high efficiency, and a long lifespan. 
     A synthesis method for the heterocyclic compound represented by Formula 1 would be apparent to those of ordinary skill in the art by referring to the following examples. 
     The heterocyclic compound represented by Formula 1 may be used between a pair of electrodes of an organic light-emitting device. For example, the heterocyclic compound may be included in at least one layer selected from a hole transport region, an electron transport region, and an emission layer. In one or more embodiments, the heterocyclic compound of Formula 1 may be used as a material for a capping layer located outside a pair of electrodes of an organic light-emitting device. 
     Accordingly, there is provided an organic light-emitting device including: a first electrode; a second electrode facing the first electrode; an organic layer between the first electrode and the second electrode and including an emission layer; and at least one heterocyclic compound represented by Formula 1. 
     In one embodiment, the organic layer of the organic light-emitting device may include at least one heterocyclic compound represented by Formula 1. 
     The expression “(an organic layer) includes at least one heterocyclic compound” as used herein may include a case in which “(an organic layer) includes identical heterocyclic compounds represented by Formula 1” or a case in which “(an organic layer) includes two or more different heterocyclic compounds represented by Formula 1”. 
     For example, the organic layer may include, as the heterocyclic compound, only Compound 1. In this regard, Compound 1 may exist only in the emission layer of the organic light-emitting device. In one or more embodiments, the organic layer may include, as the heterocyclic compound, Compound 1 and Compound 2. In this regard, Compound 1 and Compound 2 may exist in an identical layer (for example, Compound 1 and Compound 2 may all exist in an emission layer), or different layers (for example, Compound 1 may exist in an emission layer and Compound 2 may exist in an electron transport layer). 
     In one embodiment, the first electrode may be an anode, the second electrode may be a cathode, the organic layer may include the heterocyclic compound, and may further include a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode. The hole transport region may include a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof. The electron transport region includes a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof. 
     In one or more embodiments, the emission layer of the organic light-emitting device may include the condensed cyclic compound. 
     In one embodiment, the emission layer of the organic light-emitting device includes the heterocyclic compound, and the emission layer may emit blue light having a wavelength of maximum emission in a range of about 390 nm to about 440 nm. The wavelength of maximum emission of the emitted light may be confirmed by measuring an EL luminescent spectrum with an I-V-L measurement apparatus. 
     In one embodiment, the emission layer of the organic light-emitting device may include the heterocyclic compound, and the emission layer may further include a phosphorescent dopant or a fluorescent dopant. 
     For example, the fluorescent dopant may be a thermally activated delayed fluorescence (TADF) emitter satisfying Equation 1: 
       Δ E   st   =S 1− T 1≤0.3 eV.
 
     S1 is a singlet energy level of the fluorescent dopant, and 
     T1 is a triplet energy level of the fluorescent dopant. 
     S1 and T1 are simulation values obtained by quantum chemical calculation. The quantum chemical calculation may be performed by using Gaussian 09, a quantum chemical calculation program manufactured by Gaussian, Inc., USA. A density functional theory (DFT) is used for calculation. Structural optimization may be performed by time-dependent density functional theory (TD-DFT) with respect to a structure optimized by using B3LYP as a functional theory and 6-31G* as a basis function, and a calculation value of triplet energy may be obtained. 
     For example, the phosphorescent dopant may include an organometallic compound including one selected from iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), rhodium (Rh), and copper (Cu). 
     In one or more embodiments, the phosphorescent dopant may include an organometallic complex represented by Formula 401: 
     
       
         
         
             
             
         
       
     
     In Formulae 401 and 402, 
     M may be selected from iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh), and thulium (Tm), 
     L 401  may be selected from ligands represented by Formula 402, and xc1 may be 1, 2, or 3, wherein, when xc1 is two or more, two or more L 401 (s) may be identical to or different from each other, 
     L 402  may be an organic ligand, and xc2 may be an integer from 0 to 4, wherein, when xc2 is two or more, two or more L 402 (s) may be identical to or different from each other, 
     X 401  to X 404  may each independently be nitrogen or carbon, 
     X 401  and X 403  may be linked via a single bond or a double bond, and X 402  and X 404  may be linked via a single bond or a double bond, 
     A 401  and A 402  may each independently be selected from a C 5 -C 60  carbocyclic group or a C 1 -C 60  heterocyclic group, 
     X 405  may be a single bond, *—O—*′, *—S—*′, *—C(═O)—*′, *—N(Q 411 )-*′, *—C(Q 411 )(Q 412 )-*′, *—C(Q 411 )═C(Q 412 )-*′, *—C(Q 411 )=*′, or *═C(Q 411 )=*′, wherein Q 411  and Q 412  may each independently be hydrogen, deuterium, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group, 
     X 406  may be a single bond, O, or S, 
     R 401  and R 402  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 20  alkyl group, a substituted or unsubstituted C 1 -C 20  alkoxy group, a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 401 )(Q 402 )(Q 403 ), —N(Q 401 )(Q 402 ), —B(Q 401 )(Q 402 ), —C(═O)(Q 401 ), —S(═O) 2 (Q 401 ), and —P(═O)(Q 401 )(Q 402 ), wherein Q 401  to Q 403  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a C 6 -C 20  aryl group, and a C 1 -C 20  heteroaryl group, 
     xc11 and xc12 may each independently be an integer from 0 to 10, and 
     * and *′ in Formula 402 each indicate a binding site to M in Formula 401. 
     In one embodiment, the hole transport region of the organic light-emitting device may include a hole transport layer, and the hole transport layer may include a first hole transport layer and a second hole transport layer. 
     In one embodiment, the electron transport region of the organic light-emitting device may include at least one selected from a phosphine oxide-containing compound, a silyl-containing compound, and a silyl-substituted phosphine oxide-containing compound. 
     The term “an organic layer” as used herein refers to a single layer and/or a plurality of layers disposed between the first electrode and the second electrode of an organic light-emitting device. A material included in the “organic layer” is not limited to an organic material. 
     [Description of  FIG. 1 ] 
       FIG. 1  is a schematic cross-sectional view of an organic light-emitting device  10  according to an embodiment. The organic light-emitting device  10  includes a first electrode  110 , an organic layer  150 , and a second electrode  190 . 
     Hereinafter, the structure of the organic light-emitting device  10  according to an embodiment and a method of manufacturing the organic light-emitting device  10  will be described in connection with  FIG. 1 . 
     [First Electrode  110 ] 
     In  FIG. 1 , a substrate may be additionally disposed under the first electrode  110  or above the second electrode  190 . The substrate may be a glass substrate or a plastic substrate, each having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and water resistance. 
     The first electrode  110  may be formed by, for example, depositing or sputtering a material for forming the first electrode  110  on the substrate. When the first electrode  110  is an anode, the material for forming the first electrode  110  may be selected from materials with a high work function to facilitate hole injection. 
     The first electrode  110  may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. When the first electrode  110  is a transmissive electrode, a material for forming a first electrode may be selected from indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO 2 ), zinc oxide (ZnO), and any combinations thereof, but embodiments of the present disclosure are not limited thereto. In one or more embodiments, when the first electrode  110  is a semi-transmissive electrode or a reflectable electrode, a material for forming a first electrode may be selected from magnesium (Mg), silver (Ag), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), magnesium-silver (Mg—Ag), and any combinations thereof, but embodiments of the present disclosure are not limited thereto. 
     The first electrode  110  may have a single-layered structure, or a multi-layered structure including two or more layers. For example, the first electrode  110  may have a three-layered structure of ITO/Ag/ITO, but the structure of the first electrode  110  is not limited thereto. 
     [Organic Layer  150 ] 
     The organic layer  150  is disposed on the first electrode  110 . The organic layer  150  may include an emission layer. 
     The organic layer  150  may further include a hole transport region between the first electrode  110  and the emission layer and an electron transport region between the emission layer and the second electrode  190 . 
     [Hole Transport Region in Organic Layer  150 ] 
     The hole transport region may have i) a single-layered structure including a single layer including a single material, ii) a single-layered structure including a single layer including a plurality of different materials, or iii) a multi-layered structure having a plurality of layers including a plurality of different materials. 
     The hole transport region may include at least one layer selected from a hole injection layer, a hole transport layer, an emission auxiliary layer, and an electron blocking layer. 
     For example, the hole transport region may have a single-layered structure including a single layer including a plurality of different materials, or a multi-layered structure having a hole injection layer/hole transport layer structure, a hole injection layer/hole transport layer/emission auxiliary layer structure, a hole injection layer/emission auxiliary layer structure, a hole transport layer/emission auxiliary layer structure, or a hole injection layer/hole transport layer/electron blocking layer structure, wherein for each structure, constituting layers are sequentially stacked from the first electrode  110  in this stated order, but the structure of the hole transport region is not limited thereto. 
     The hole transport region may include at least one selected from m-MTDATA, TDATA, 2-TNATA, NPB(NPD), β-NPB, TPD, spiro-TPD, spiro-NPB, methylated-NPB, TAPC, HMTPD, 4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzenesulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphor sulfonic acid (PANI/CSA), polyaniline/poly(4-styrenesulfonate) (PANI/PSS), a compound represented by Formula 201, and a compound represented by Formula 202: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     In Formulae 201 and 202, 
     L 201  to L 204  may each independently be selected from a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, 
     L 205  may be selected from *—O—*′, *—S—*′, *—N(Q 201 )-*′, a substituted or unsubstituted C 1 -C 20  alkylene group, a substituted or unsubstituted C 2 -C 20  alkenylene group, a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, 
     xa1 to xa4 may each independently be an integer from 0 to 3, 
     xa5 may be an integer from 1 to 10, and 
     R 201  to R 204  and Q 201  may each independently be selected from a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group. 
     In one embodiment, in Formula 202, R 201  and R 202  may optionally be linked via a single bond, a dimethyl-methylene group, or a diphenyl-methylene group, and R 203  and R 204  may optionally be linked via a single bond, a dimethyl-methylene group, or a diphenyl-methylene group. 
     In one embodiment, in Formulae 201 and 202, 
     L 201  to L 205  may each independently be selected from: 
     a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group; and 
     a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an indacenylene group, an acenaphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a rubicenylene group, a coronenylene group, an ovalenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C 1 -C 10  alkyl group, a phenyl group substituted with —F, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, —Si(Q 31 )(Q 32 )(Q 33 ), and —N(Q 31 )(Q 32 ), and 
     Q 31  to Q 33  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group. 
     In one or more embodiments, xa1 to xa4 may each independently be 0, 1, or 2. 
     In one or more embodiments, xa5 may be 1, 2, 3, or 4. 
     In one or more embodiments, R 201  to R 204  and Q 201  may each independently be selected from: 
     a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group; and 
     a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C 1 -C 10  alkyl group, a phenyl group substituted with —F, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, —Si(Q 31 )(Q 32 )(Q 33 ), and —N(Q 31 )(Q 32 ), and 
     Q 31  to Q 33  are the same as described above. 
     In one or more embodiments, at least one selected from R 201  to R 203  in Formula 201 may each independently be selected from: 
     a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and 
     a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C 1 -C 10  alkyl group, a phenyl group substituted with —F, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, 
     but embodiments of the present disclosure are not limited thereto. 
     In one or more embodiments, in Formula 202, i) R 201  and R 202  may be linked via a single bond, and/or ii) R 203  and R 204  may be linked via a single bond. 
     In one or more embodiments, at least one selected from R 201  to R 204  in Formula 202 may be selected from: 
     a carbazolyl group; and 
     a carbazolyl group substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C 1 -C 10  alkyl group, a phenyl group substituted with —F, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, 
     but embodiments of the present disclosure are not limited thereto. 
     The compound represented by Formula 201 may be represented by Formula 201A: 
     
       
         
         
             
             
         
       
     
     In one embodiment, the compound represented by Formula 201 may be represented by Formula 201A(1), but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
     
     In one embodiment, the compound represented by Formula 201 may be represented by Formula 201A-1, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
     
     In one embodiment, the compound represented by Formula 202 may be represented by Formula 202A: 
     
       
         
         
             
             
         
       
     
     In one embodiment, the compound represented by Formula 202 may be represented by Formula 202A-1: 
     
       
         
         
             
             
         
       
     
     In Formulae 201A, 201A(1), 201A-1, 202A, and 202A-1, 
     L 201  to L 203 , xa1 to xa3, xa5, and R 202  to R 204  are the same as described above, 
     R 211  and R 212  may each independently be the same as defined in connection with R 203 , and 
     R 213  to R 217  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a phenyl group substituted with a C 1 -C 10  alkyl group, a phenyl group substituted with —F, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group. 
     The hole transport region may include at least one compound selected from Compounds HT1 to HT39, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     A thickness of the hole transport region may be in a range of about 100 Å to about 10,000 Å, for example, about 100 Å to about 1000 Å. When the hole transport region includes at least one of a hole injection layer and a hole transport layer, a thickness of the hole injection layer may be in a range of about 100 Å to about 9,000 Å, for example, about 100 Å to about 1,000 Å, and a thickness of the hole transport layer may be in a range of about 50 Å to about 2,000 Å, for example about 100 Å to about 1,500 Å. When the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within these ranges, satisfactory hole transporting characteristics may be obtained without a substantial increase in driving voltage. 
     The emission auxiliary layer may increase light-emission efficiency by compensating for an optical resonance distance according to the wavelength of light emitted by an emission layer, and the electron blocking layer may block the flow of electrons from an electron transport region. The emission auxiliary layer and the electron blocking layer may include the materials as described above. 
     [p-Dopant] 
     The hole transport region may further include, in addition to these materials, a charge-generation material for the improvement of conductive properties. The charge-generation material may be homogeneously or non-homogeneously dispersed in the hole transport region. 
     The charge-generation material may be, for example, a p-dopant. 
     In one embodiment, the hole transport region may further include a p-dopant having a lowest unoccupied molecular orbital (LUMO) energy level of about −3.5 eV or less. 
     The p-dopant may include at least one selected from a quinone derivative, a metal oxide, and a cyano group-containing compound, but embodiments of the present disclosure are not limited thereto. 
     In one embodiment, the p-dopant may include at least one selected from: 
     a quinone derivative, such as tetracyanoquinodimethane (TCNQ) or 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane (F4-TCNQ); 
     a metal oxide, such as tungsten oxide or molybdenum oxide; 
     1,4,5,8,9,12-hexazatriphenylene-hexacarbonitrile (HAT-CN); and 
     a compound represented by Formula 221, 
     but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
     
     In Formula 221, 
     R 221  to R 223  may each independently be selected from a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, wherein at least one selected from R 221  to R 223  may have at least one substituent selected from a cyano group, —F, —Cl, —Br, —I, a C 1 -C 20  alkyl group substituted with —F, a C 1 -C 20  alkyl group substituted with —Cl, a C 1 -C 20  alkyl group substituted with —Br, and a C 1 -C 20  alkyl group substituted with —I. 
     [Emission Layer in Organic Layer  150 ] 
     When the organic light-emitting device  10  is a full-color organic light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, or a blue emission layer, according to a sub-pixel. In one or more embodiments, the emission layer may have a stacked structure of two or more layers selected from a red emission layer, a green emission layer, and a blue emission layer, in which the two or more layers contact each other or are separated from each other. In one or more embodiments, the emission layer may include two or more materials selected from a red light-emitting material, a green light-emitting material, and a blue light-emitting material, in which the two or more materials are mixed with each other in a single layer to emit white light. 
     The emission layer may include a host and a dopant. The dopant may include at least one selected from a phosphorescent dopant and a fluorescent dopant. 
     An amount of the dopant in the emission layer may be in a range of about 0.01 parts by weight to about 15 parts by weight based on 100 parts by weight of the host, but embodiments of the present disclosure are not limited thereto. 
     A thickness of the emission layer may be in a range of about 100 Å to about 1,000 Å, for example, about 200 Å to about 600 Å. When the thickness of the emission layer is within this range, excellent light-emission characteristics may be obtained without a substantial increase in driving voltage. 
     [Host in Emission Layer] 
     The host may include the heterocyclic compound represented by Formula 1. 
     In one or more embodiments, the host may further include a compound represented by Formula 301: 
       [Ar 301 ] xb11 -[(L 301 ) xb1 -R 301 ] xb21   &lt;Formula 301&gt;
 
     In Formula 301, 
     Ar 301  may be a substituted or unsubstituted C 5 -C 60  carbocyclic group or a substituted or unsubstituted C 1 -C 60  heterocyclic group, 
     xb11 may be 1, 2, or 3, 
     L 301  may be selected from a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, 
     xb1 may be an integer from 0 to 5, 
     R 301  may be selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 60  alkyl group, a substituted or unsubstituted C 2 -C 60  alkenyl group, a substituted or unsubstituted C 2 -C 60  alkynyl group, a substituted or unsubstituted C 1 -C 60  alkoxy group, a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 301 )(Q 302 )(Q 303 ), —N(Q 301 )(Q 302 ), —B(Q 301 )(Q 302 ), —C(═O)(Q 301 ), —S(═O) 2 (Q 301 ), and —P(═O)(Q 301 )(Q 302 ), 
     xb21 may be an integer from 1 to 5, and 
     Q 301  to Q 303  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group, but embodiments of the present disclosure are not limited thereto. 
     In one embodiment, Ar 301  in Formula 301 may be selected from: 
     a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, and a dibenzothiophene group; and 
     a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, and a dibenzothiophene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), and 
     Q 31  to Q 33  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group, but embodiments of the present disclosure are not limited thereto. 
     When xb11 in Formula 301 is two or more, two or more Ar 301 (s) may be linked via a single bond. 
     In one or more embodiments the compound represented by Formula 301 may be represented by Formula 301-1 or 301-2: 
     
       
         
         
             
             
         
       
     
     In Formulae 301-1 and 301-2, 
     ring A 301  to ring A 304  may each independently be selected from a benzene ring, a naphthalene ring, a phenanthrene ring, a fluoranthene ring, a triphenylene ring, a pyrene ring, a chrysene ring, a pyridine ring, a pyrimidine ring, an indene ring, a fluorene ring, a spiro-bifluorene ring, a benzofluorene ring, a dibenzofluorene ring, an indole ring, a carbazole ring, a benzocarbazole ring, a dibenzocarbazole ring, a furan ring, a benzofuran ring, a dibenzofuran ring, a naphthofuran ring, a benzonaphthofuran ring, a dinaphthofuran ring, a thiophene ring, a benzothiophene ring, a dibenzothiophene ring, a naphthothiophene ring, a benzonaphthothiophene group ring, and a dinaphthothiophene group ring, 
     X 301  may be O, S, or N-[(L 304 ) xb4 -R 304 ], 
     R 311  to R 314  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), 
     xb22 and xb23 may each independently be 0, 1 or 2, 
     L 301 , xb1, R 301 , and Q 31  to Q 33  are the same as described above, 
     L 302  to L 304  may each independently be the same as defined in connection with L 301 , 
     xb2 to xb4 may each independently be the same as defined in connection with xb1, and 
     R 302  to R 304  may each independently be the same as defined in connection with R 301 . 
     For example, in Formulae 301, 301-1, and 301-2, L 301  to L 304  may each independently be selected from: 
     a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group; and 
     a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), and 
     Q 31  to Q 33  are the same as described above. 
     In one embodiment, R 301  to R 304  in Formulae 301, 301-1 and 301-2 may each independently be selected from: 
     a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group; and 
     a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an azacarbazolyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), and 
     Q 31  to Q 33  are the same as described above. 
     In one or more embodiments, the host may include an alkaline earth metal complex. For example, the host may be selected from a Be complex (for example, Compound H55), a Mg complex, and a Zn complex. 
     The host may include at least one selected from 9,10-di(2-naphthyl)anthracene (ADN), 2-methyl-9,10-bis(naphthalen-2-yl)anthracene (MADN), 9,10-di-(2-naphthyl)-2-t-butyl-anthracene (TBADN), 4,4′-bis(N-carbazolyl)-1,1′-biphenyl (CBP), 1,3-di-9-carbazolylbenzene (mCP), 1,3,5-tri(carbazol-9-yl)benzene (TCP), and Compounds H1 to H55, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     [Phosphorescent Dopant Included in Emission Layer in Organic Layer  150 ] 
     The phosphorescent dopant may include an organometallic complex represented by Formula 401: 
     
       
         
         
             
             
         
       
     
     In Formulae 401 and 402, 
     M may be selected from iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh), and thulium (Tm), 
     L 401  may be selected from ligands represented by Formula 402, and xc1 may be 1, 2, or 3, wherein, when xc1 is two or more, two or more L 401 (s) may be identical to or different from each other, 
     L 402  may be an organic ligand, and xc2 may be an integer from 0 to 4, wherein, when xc2 is two or more, two or more L 402 (s) may be identical to or different from each other, 
     X 401  to X 404  may each independently be nitrogen or carbon, 
     X 401  and X 403  may be linked via a single bond or a double bond, and X 402  and X 404  may be linked via a single bond or a double bond, 
     A 401  and A 402  may each independently be selected from a C 5 -C 60  carbocyclic group or a C 1 -C 60  heterocyclic group, 
     X 405  may be a single bond, *—O—*′, *—S—*′, *—C(═O)—*′, *—N(Q 411 )-*′, *—C(Q 411 )(Q 412 )-*′, *—C(Q 411 )=C(Q 412 )-*′, *—C(Q 411 )=*′, or *═C(Q 411 )=*′, wherein Q 411  and Q 412  may each independently be hydrogen, deuterium, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group, 
     X 406  may be a single bond, O, or S, 
     R 401  and R 402  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 20  alkyl group, a substituted or unsubstituted C 1 -C 20  alkoxy group, a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 401 )(Q 402 )(Q 403 ), —N(Q 401 )(Q 402 ), —B(Q 401 )(Q 402 ), —C(═O)(Q 401 ), —S(═O) 2 (Q 401 ), and —P(═O)(Q 401 )(Q 402 ), wherein Q 401  to Q 403  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a C 6 -C 20  aryl group, and a C 1 -C 20  heteroaryl group, 
     xc11 and xc12 may each independently be an integer from 0 to 10, and 
     * and *′ in Formula 402 each indicate a binding site to M in Formula 401. 
     In one embodiment, A 401  and A 402  in Formula 402 may each independently be selected from a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, an indene group, a pyrrole group, a thiophene group, a furan group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a quinoxaline group, a quinazoline group, a carbazole group, a benzimidazole group, a benzofuran group, a benzothiophene group, an isobenzothiophene group, an imidazopyridine group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a dibenzofuran group, and a dibenzothiophene group. 
     In one or more embodiments, in Formula 402, i) X 401  may be nitrogen, and X 402  may be carbon, or ii) X 401  and X 402  may each be nitrogen at the same time. 
     In one or more embodiments, R 401  and R 402  in Formula 402 may each independently be selected from: 
     hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, and a C 1 -C 20  alkoxy group; 
     a C 1 -C 20  alkyl group and a C 1 -C 20  alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a phenyl group, a naphthyl group, a cyclopentyl group, a cyclohexyl group, an adamantly group, a norbornanyl group, and a norbornenyl group; 
     a cyclopentyl group, a cyclohexyl group, an adamantly group, a norbornanyl group, a norbornenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; 
     a cyclopentyl group, a cyclohexyl group, an adamantly group, a norbornanyl group, a norbornenyl group a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a cyclopentyl group, a cyclohexyl group, an adamantly group, a norbornanyl group, a norbornenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and 
     —Si(Q 401 )(Q 402 )(Q 403 ), —N(Q 401 )(Q 402 ), —B(Q 401 )(Q 402 ), —C(═O)(Q 401 ), —S(═O) 2 (Q 401 ), and —P(═O)(Q 401 )(Q 402 ), and 
     Q 401  to Q 403  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, and a naphthyl group, but embodiments of the present disclosure are not limited thereto. 
     In one or more embodiments, when xc1 in Formula 401 is two or more, two A 401 (s) in two or more L 401 (s) may optionally be linked via X 407 , which is a linking group, or two A 402 (s) in two or more L 401 (s) may optionally be linked via X 408 , which is a linking group (see Compounds PD1 to PD4 and PD7). X 407  and X 408  may each independently be a single bond, *—O—*′, *—S—*′, *—C(═O)—*′, *—N(Q 413 )-*′, *—C(Q 413 )(Q 414 )-*′, or *—C(Q 413 )=C(Q 414 )-*′ (wherein Q 413  and Q 414  may each independently be hydrogen, deuterium, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group), but are not limited thereto. 
     L 402  in Formula 401 may be a monovalent, divalent, or trivalent organic ligand. For example, L 402  may be selected from halogen, diketone (for example, acetylacetonate), carboxylic acid (for example, picolinate), —C(═O), isonitrile, —CN, and phosphorus (for example, phosphine, or phosphite), but embodiments of the present disclosure are not limited thereto. 
     In one or more embodiments, the phosphorescent dopant may be selected from, for example, Compounds PD1 to PD26, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     [Fluorescent Dopant in Emission Layer] 
     The fluorescent dopant may include an arylamine compound or a styrylamine compound. 
     The fluorescent dopant may include a compound represented by Formula 501: 
     
       
         
         
             
             
         
       
     
     In Formula 501, 
     Ar 501  may be a substituted or unsubstituted C 5 -C 60  carbocyclic group or a substituted or unsubstituted C 1 -C 60  heterocyclic group, 
     L 501  to L 503  may each independently be selected from a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, 
     xd1 to xd3 may each independently be an integer of 0 to 3, 
     R 501  and R 502  may each independently be selected from a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, 
     xd4 may be an integer of 1 to 6. 
     In one embodiment, Ar 501  in Formula 501 may be selected from: 
     a naphthalene group, a heptalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, and an indenophenanthrene group; and 
     a naphthalene group, a heptalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, and an indenophenanthrene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group. 
     In one or more embodiments, L 501  to L 503  in Formula 501 may each independently be selected from: 
     a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group; and 
     a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, and a pyridinylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group. 
     In one or more embodiments, R 501  and R 502  in Formula 501 may each independently be selected from: 
     a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group; and 
     a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, and a pyridinyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group and —Si(Q 31 )(Q 32 )(Q 33 ), and 
     Q 31  to Q 33  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group. 
     In one or more embodiments, xd4 in Formula 501 may be 2, but embodiments of the present disclosure are not limited thereto. 
     For example, the fluorescent dopant may be selected from Compounds FD1 to FD22: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     In one or more embodiments, the fluorescent dopant may be selected from the following compounds, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
     
     [Electron Transport Region in Organic Layer  150 ] 
     The electron transport region may have i) a single-layered structure including a single layer including a single material, ii) a single-layered structure including a single layer including a plurality of different materials, or iii) a multi-layered structure having a plurality of layers including a plurality of different materials. 
     The electron transport region may include at least one selected from a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, and an electron injection layer, but embodiments of the present disclosure are not limited thereto. 
     For example, the electron transport region may have an electron transport layer/electron injection layer structure, a hole blocking layer/electron transport layer/electron injection layer structure, an electron control layer/electron transport layer/electron injection layer structure, or a buffer layer/electron transport layer/electron injection layer structure, wherein for each structure, constituting layers are sequentially stacked from an emission layer. However, embodiments of the structure of the electron transport region are not limited thereto. 
     The electron transport region (for example, a buffer layer, a hole blocking layer, an electron control layer, or an electron transport layer in the electron transport region) may include a metal-free compound containing at least one π electron-depleted nitrogen-containing ring. 
     The “π electron-depleted nitrogen-containing ring” indicates a C 1 -C 60  heterocyclic group having at least one *—N═*′ moiety as a ring-forming moiety. 
     For example, the “π electron-depleted nitrogen-containing ring” may be i) a 5-membered to 7-membered heteromonocyclic group having at least one *—N═*′ moiety, ii) a heteropolycyclic group in which two or more 5-membered to 7-membered heteromonocyclic groups each having at least one *—N═*′ moiety are condensed with each other, or iii) a heteropolycyclic group in which at least one of 5-membered to 7-membered heteromonocyclic groups, each having at least one *—N═*′ moiety, is condensed with at least one C 5 -C 60  carbocyclic group. 
     Examples of the π electron-depleted nitrogen-containing ring include an imidazole, a pyrazole, a thiazole, an isothiazole, an oxazole, an isoxazole, a pyridine, a pyrazine, a pyrimidine, a pyridazine, an indazole, a purine, a quinoline, an isoquinoline, a benzoquinoline, a phthalazine, a naphthyridine, a quinoxaline, a quinazoline, a cinnoline, a phenanthridine, an acridine, a phenanthroline, a phenazine, a benzimidazole, an isobenzothiazole, a benzoxazole, an isobenzoxazole, a triazole, a tetrazole, an oxadiazole, a triazine, a thiadiazol, an imidazopyridine, an imidazopyrimidine, and an azacarbazole, but are not limited thereto. 
     For example, the electron transport region may include a compound represented by Formula 601: 
       [Ar 601 ] xe11 -[(L 601 ) xe1 -R 601 ] xe21   &lt;Formula 601&gt;
 
     In Formula 601, 
     Ar 601  may be a substituted or unsubstituted C 5 -C 60  carbocyclic group or a substituted or unsubstituted C 1 -C 60  heterocyclic group, 
     xe11 may be 1, 2, or 3, 
     L 601  may be selected from a substituted or unsubstituted C 3 -C 10  cycloalkylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10  cycloalkenylene group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60  arylene group, a substituted or unsubstituted C 1 -C 60  heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, 
     xe1 may be an integer from 0 to 5, 
     R 601  may be selected from a substituted or unsubstituted C 3 -C 10  cycloalkyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10  cycloalkenyl group, a substituted or unsubstituted C 1 -C 10  heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60  aryl group, a substituted or unsubstituted C 6 -C 60  aryloxy group, a substituted or unsubstituted C 6 -C 60  arylthio group, a substituted or unsubstituted C 1 -C 60  heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 601 )(Q 602 )(Q 603 ), —C(═O)(Q 601 ), —S(═O) 2 (Q 601 ), and —P(═O)(Q 601 )(Q 602 ), and 
     Q 601  to Q 603  may each independently be a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group, and 
     xe21 may be an integer from 1 to 5. 
     In one embodiment, at least one of Ar 601 (s) in the number of xe11 and R 601 (s) in the number of xe21 may include the π electron-depleted nitrogen-containing ring. 
     In one embodiment, Ar 601  in Formula 601 may be selected from: 
     a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an isobenzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group; and 
     a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pentaphene group, an indenoanthracene group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, an indazole group, a purine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a phthalazine group, a naphthyridine group, a quinoxaline group, a quinazoline group, a cinnoline group, a phenanthridine group, an acridine group, a phenanthroline group, a phenazine group, a benzimidazole group, an isobenzothiazole group, a benzoxazole group, an isobenzoxazole group, a triazole group, a tetrazole group, an oxadiazole group, a triazine group, a thiadiazole group, an imidazopyridine group, an imidazopyrimidine group, and an azacarbazole group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), and 
     Q 31  to Q 33  may each independently be selected from a C 1 -C 10  alkyl group, a C 1 -C 10  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group. 
     When xe11 in Formula 601 is two or more, two or more Ar 601 (s) may be linked via a single bond. 
     In one or more embodiments, Ar 601  in Formula 601 may be an anthracene group. 
     In one or more embodiments, a compound represented by Formula 601 may be represented by Formula 601-1: 
     
       
         
         
             
             
         
       
     
     In Formula 601-1, 
     X 614  may be N or C(R 614 ), X 615  may be N or C(R 615 ), X 616  may be N or C(R 616 ), and at least one selected from X 614  to X 616  may be N, 
     L 611  to L 613  may each independently be the same as described in connection with L 601 , 
     xe611 to xe613 may each independently be defined the same as xe1, 
     R 611  to R 613  may each independently be the same as described in connection with R 601 , and 
     R 614  to R 616  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group. 
     In one embodiment, L 601  and L 611  to L 613  in Formulae 601 and 601-1 may each independently be selected from: 
     a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group; and 
     a phenylene group, a naphthylene group, a fluorenylene group, a spiro-bifluorenylene group, a benzofluorenylene group, a dibenzofluorenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a perylenylene group, a pentaphenylene group, a hexacenylene group, a pentacenylene group, a thiophenylene group, a furanylene group, a carbazolylene group, an indolylene group, an isoindolylene group, a benzofuranylene group, a benzothiophenylene group, a dibenzofuranylene group, a dibenzothiophenylene group, a benzocarbazolylene group, a dibenzocarbazolylene group, a dibenzosilolylene group, a pyridinylene group, an imidazolylene group, a pyrazolylene group, a thiazolylene group, an isothiazolylene group, an oxazolylene group, an isoxazolylene group, a thiadiazolylene group, an oxadiazolylene group, a pyrazinylene group, a pyrimidinylene group, a pyridazinylene group, a triazinylene group, a quinolinylene group, an isoquinolinylene group, a benzoquinolinylene group, a phthalazinylene group, a naphthyridinylene group, a quinoxalinylene group, a quinazolinylene group, a cinnolinylene group, a phenanthridinylene group, an acridinylene group, a phenanthrolinylene group, a phenazinylene group, a benzimidazolylene group, an isobenzothiazolylene group, a benzoxazolylene group, an isobenzoxazolylene group, a triazolylene group, a tetrazolylene group, an imidazopyridinylene group, an imidazopyrimidinylene group, and an azacarbazolylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group, 
     but embodiments of the present disclosure are not limited thereto. 
     In one or more embodiments, xe1 and xe611 to xe613 in Formulae 601 and 601-1 may each independently be 0, 1, or 2. 
     In one or more embodiments, R 601  and R 611  to R 613  in Formula 601 and 601-1 may each independently be selected from: 
     a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group; 
     a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20  alkyl group, a C 1 -C 20  alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a thiophenyl group, a furanyl group, a carbazolyl group, an indolyl group, an isoindolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a dibenzosilolyl group, a pyridinyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a thiadiazolyl group, an oxadiazolyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a phenanthridinyl group, an acridinyl group, a phenanthrolinyl group, a phenazinyl group, a benzimidazolyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, and an azacarbazolyl group; and 
     —S(═O) 2 (Q 601 ) and —P(═O)(Q 601 )(Q 602 ), and 
     Q 601  and Q 602  are the same as described above. 
     The electron transport region may include at least one compound selected from Compounds ET1 to ET36, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     In one or more embodiments, the electron transport region may include at least one compound selected from 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 4,7-diphenyl-1,10-phenanthroline (Bphen), Alq 3 , BAlq, 3-(biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole (TAZ), and NTAZ. 
     
       
         
         
             
             
         
       
     
     A thickness of the buffer layer, the hole blocking layer, or the electron control layer may be in a range of about 20 Å to about 1000 Å, for example, about 30 Å to about 300 Å. When the thicknesses of the buffer layer, the hole blocking layer, and the electron control layer are within these ranges, the electron transport region may have excellent hole blocking characteristics or electron control characteristics without a substantial increase in driving voltage. 
     A thickness of the electron transport layer may be in a range of about 100 Å to about 1,000 Å, for example, about 150 Å to about 500 Å. When the thickness of the electron transport layer is within the range described above, satisfactory electron transport characteristics without a substantial increase in driving voltage may be obtained. 
     The electron transport region (for example, the electron transport layer in the electron transport region) may further include, in addition to the materials described above, a metal-containing material. 
     The metal-containing material may include at least one selected from alkali metal complex and alkaline earth-metal complex. The alkali metal complex may include a metal ion selected from a Li ion, a Na ion, a K ion, a Rb ion, and a Cs ion, and the alkaline earth-metal complex may include a metal ion selected from a Be ion, a Mg ion, a Ca ion, a Sr ion, and a Ba ion. A ligand coordinated with the metal ion of the alkali metal complex or the alkaline earth-metal complex may be selected from a hydroxy quinoline, a hydroxy isoquinoline, a hydroxy benzoquinoline, a hydroxy acridine, a hydroxy phenanthridine, a hydroxy phenyloxazole, a hydroxy phenylthiazole, a hydroxy diphenyloxadiazole, a hydroxy diphenylthiadiazol, a hydroxy phenylpyridine, a hydroxy phenylbenzimidazole, a hydroxy phenylbenzothiazole, a bipyridine, a phenanthroline, and a cyclopentadiene, but embodiments of the present disclosure are not limited thereto. 
     For example, the metal-containing material may include a Li complex. The Li complex may include, for example, Compound ET-D1 (lithium quinolate, LiQ) or ET-D2: 
     
       
         
         
             
             
         
       
     
     The electron transport region may include an electron injection layer that facilitates electron injection from the second electrode  190 . The electron injection layer may directly contact the second electrode  190 . 
     The electron injection layer may have i) a single-layered structure including a single layer including a single material, ii) a single-layered structure including a single layer including a plurality of different materials, or iii) a multi-layered structure having a plurality of layers including a plurality of different materials. 
     The electron injection layer may include an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth-metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth-metal complex, a rare earth metal complex, or any combinations thereof. 
     The alkali metal may be selected from Li, Na, K, Rb, and Cs. In one embodiment, the alkali metal may be Li, Na, or Cs. In one or more embodiments, the alkali metal may be Li or Cs, but embodiments of the present disclosure are not limited thereto. 
     The alkaline earth metal may be selected from Mg, Ca, Sr, and Ba. 
     The rare earth metal may be selected from Sc, Y, Ce, Tb, Yb, and Gd. 
     The alkali metal compound, the alkaline earth-metal compound, and the rare earth metal compound may be selected from oxides and halides (for example, fluorides, chlorides, bromides, or iodides) of the alkali metal, the alkaline earth-metal, and the rare earth metal. 
     The alkali metal compound may be selected from alkali metal oxides, such as Li 2 O, Cs 2 O, or K 2 O, and alkali metal halides, such as LiF, NaF, CsF, KF, LiI, NaI, CsI, or KI. In one embodiment, the alkali metal compound may be selected from LiF, Li 2 O, NaF, LiI, NaI, CsI, and KI, but embodiments of the present disclosure are not limited thereto. 
     The alkaline earth-metal compound may be selected from alkaline earth-metal oxides, such as BaO, SrO, CaO, Ba x Sr 1-x O (0&lt;x&lt;1), or Ba x Ca 1-x O (0&lt;x&lt;1). In one embodiment, the alkaline earth-metal compound may be selected from BaO, SrO, and CaO, but embodiments of the present disclosure are not limited thereto. 
     The rare earth metal compound may be selected from YbF 3 , ScF 3 , Sc 2 O 3 , Y 2 O 3 , Ce 2 O 3 , GdF 3 , and TbF 3 . In one embodiment, the rare earth metal compound may be selected from YbF 3 , ScF 3 , TbF 3 , YbI 3 , ScI 3 , and TbI 3 , but embodiments of the present disclosure are not limited thereto. 
     The alkali metal complex, the alkaline earth-metal complex, and the rare earth metal complex may include an ion of alkali metal, alkaline earth-metal, and rare earth metal as described above, and a ligand coordinated with a metal ion of the alkali metal complex, the alkaline earth-metal complex, or the rare earth metal complex may be selected from hydroxy quinoline, hydroxy isoquinoline, hydroxy benzoquinoline, hydroxy acridine, hydroxy phenanthridine, hydroxy phenyloxazole, hydroxy phenylthiazole, hydroxy diphenyloxadiazole, hydroxy diphenylthiadiazol, hydroxy phenylpyridine, hydroxy phenylbenzimidazole, hydroxy phenylbenzothiazole, bipyridine, phenanthroline, and cyclopentadiene, but embodiments of the present disclosure are not limited thereto. 
     The electron injection layer may consist of an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth-metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth-metal complex, a rare earth metal complex, or any combinations thereof, as described above. In one or more embodiments, the electron injection layer may further include an organic material. When the electron injection layer further includes an organic material, an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth-metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth-metal complex, a rare earth metal complex, or any combinations thereof may be homogeneously or non-homogeneously dispersed in a matrix including the organic material. 
     A thickness of the electron injection layer may be in a range of about 1 Å to about 100 Å, for example, about 3 Å to about 90 Å. When a thickness of the electron injection layer is within these ranges, satisfactory electron injection characteristics may be obtained without substantial increase in driving voltage. 
     [Second Electrode  190 ] 
     The second electrode  190  may be disposed on the organic layer  150  having such a structure. The second electrode  190  may be a cathode which is an electron injection electrode, and in this regard, a material for forming the second electrode  190  may be selected from metal, an alloy, an electrically conductive compound, and a combination thereof, which have a relatively low work function. 
     The second electrode  190  may include at least one selected from lithium (Li), silver (Ag), magnesium (Mg), aluminum (Al), aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), magnesium-silver (Mg—Ag), ITO, and IZO, but embodiments of the present disclosure are not limited thereto. The second electrode  190  may be a transmissive electrode, a semi-transmissive electrode, or a reflective electrode. 
     The second electrode  190  may have a single-layered structure, or a multi-layered structure including two or more layers. 
     [Description of  FIGS. 2 to 4 ] 
       FIG. 2  is a schematic view of an organic light-emitting device  20  according to an embodiment. The organic light-emitting device  20  includes a first capping layer  210 , the first electrode  110 , the organic layer  150 , and the second electrode  190 , which are sequentially stacked in this stated order.  FIG. 3  is a schematic view of an organic light-emitting device  30  according to an embodiment. The organic light-emitting device  30  includes the first electrode  110 , the organic layer  150 , the second electrode  190 , and a second capping layer  220 , which are sequentially stacked in this stated order.  FIG. 4  is a schematic view of an organic light-emitting device  40  according to an embodiment. The organic light-emitting device  40  includes the first capping layer  210 , the first electrode  110 , the organic layer  150 , the second electrode  190 , and the second capping layer  220 , which are sequentially stacked in this stated order. 
     Regarding  FIGS. 2 to 4 , the first electrode  110 , the organic layer  150 , and the second electrode  190  may be understood by referring to the description presented in connection with  FIG. 1 . 
     In the organic layer  150  of each of the organic light-emitting devices  20  and  40 , light generated in an emission layer may pass through the first electrode  110  and the first capping layer  210  toward the outside, wherein the first electrode  110  may be a semi-transmissive electrode or a transmissive electrode. In the organic layer  150  of each of the organic light-emitting devices  30  and  40 , light generated in an emission layer may pass through the second electrode  190  and the second capping layer  220  toward the outside, wherein the second electrode  190  may be a semi-transmissive electrode or a transmissive electrode. 
     The first capping layer  210  and the second capping layer  220  may increase external luminescent efficiency according to the principle of constructive interference. 
     The first capping layer  210  and the second capping layer  220  may each independently be an organic capping layer including an organic material, an inorganic capping layer including an inorganic material, or a composite capping layer including an organic material and an inorganic material. 
     At least one selected from the first capping layer  210  and the second capping layer  220  may each independently include at least one material selected from carbocyclic compounds, heterocyclic compounds, amine-based compounds, porphyrine derivatives, phthalocyanine derivatives, a naphthalocyanine derivatives, alkali metal complexes, and alkaline earth-based complexes. The carbocyclic compound, the heterocyclic compound, and the amine-based compound may be optionally substituted with a substituent containing at least one element selected from O, N, S, Se, Si, F, Cl, Br, and I. In one embodiment, at least one selected from the first capping layer  210  and the second capping layer  220  may each independently include an amine-based compound. 
     In one embodiment, at least one selected from the first capping layer  210  and the second capping layer  220  may each independently include the compound represented by Formula 201 or the compound represented by Formula 202. 
     In one or more embodiments, at least one selected from the first capping layer  210  and the second capping layer  220  may each independently include a compound selected from Compounds HT28 to HT33 and Compounds CP1 to CP5, but embodiments of the present disclosure are not limited thereto: 
     
       
         
         
             
             
         
       
     
     Hereinbefore, the organic light-emitting device according to an embodiment has been described in connection with  FIGS. 1 to 4 , but embodiments of the present disclosure are not limited thereto. 
     Layers constituting the hole transport region, an emission layer, and layers constituting the electron transport region may be formed in a certain region by using one or more suitable methods selected from vacuum deposition, spin coating, casting, Langmuir-Blodgett (LB) deposition, ink-jet printing, laser-printing, and laser-induced thermal imaging. 
     When layers constituting the hole transport region, an emission layer, and layers constituting the electron transport region are formed by vacuum deposition, the deposition may be performed at a deposition temperature of about 100° C. to about 500° C., a vacuum degree of about 10 −8  torr to about 10 −3  torr, and a deposition speed of about 0.01 Å/sec to about 100 Å/sec by taking into account a material to be included in a layer to be formed, and the structure of a layer to be formed. 
     When layers constituting the hole transport region, an emission layer, and layers constituting the electron transport region are formed by spin coating, the spin coating may be performed at a coating speed of about 2,000 rpm to about 5,000 rpm and at a heat treatment temperature of about 80° C. to about 200° C. by taking into account a material to be included in a layer to be formed, and the structure of a layer to be formed. 
     [General Definition of Substituents] 
     The term “C 1 -C 60  alkyl group” as used herein refers to a linear or branched aliphatic saturated hydrocarbon monovalent group having 1 to 60 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an isoamyl group, and a hexyl group. The term “C 1 -C 60  alkylene group” as used herein refers to a divalent group having the same structure as the C 1 -C 60  alkyl group. 
     The term “C 2 -C 60  alkenyl group” as used herein refers to a hydrocarbon group having at least one carbon-carbon double bond in the middle or at the terminus of the C 2 -C 60  alkyl group, and examples thereof include an ethenyl group, a propenyl group, and a butenyl group. The term “C 2 -C 60  alkenylene group” as used herein refers to a divalent group having the same structure as the C 2 -C 60  alkenyl group. 
     The term “C 2 -C 60  alkynyl group” as used herein refers to a hydrocarbon group having at least one carbon-carbon triple bond in the middle or at the terminus of the C 2 -C 60  alkyl group, and examples thereof include an ethynyl group, and a propynyl group. 
     The term “C 2 -C 60  alkynylene group” as used herein refers to a divalent group having the same structure as the C 2 -C 60  alkynyl group. 
     The term “C 1 -C 60  alkoxy group” as used herein refers to a monovalent group represented by —OA 101  (wherein A 101  is the C 1 -C 60  alkyl group), and examples thereof include a methoxy group, an ethoxy group, and an isopropyloxy group. 
     The term “C 3 -C 10  cycloalkyl group” as used herein refers to a monovalent saturated hydrocarbon monocyclic group having 3 to 10 carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group. The term “C 3 -C 10  cycloalkylene group” as used herein refers to a divalent group having the same structure as the C 3 -C 10  cycloalkyl group. 
     The term “C 1 -C 10  heterocycloalkyl group” as used herein refers to a monovalent monocyclic group having at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom and 1 to 10 carbon atoms, and examples thereof include a 1,2,3,4-oxatriazolidinyl group, a tetrahydrofuranyl group, and a tetrahydrothiophenyl group. The term “C 1 -C 10  heterocycloalkylene group” as used herein refers to a divalent group having the same structure as the C 1 -C 10  heterocycloalkyl group. 
     The term C 3 -C 10  cycloalkenyl group used herein refers to a monovalent monocyclic group that has 3 to 10 carbon atoms and at least one carbon-carbon double bond in the ring thereof and no aromaticity, and examples thereof include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. The term “C 3 -C 10  cycloalkenylene group” as used herein refers to a divalent group having the same structure as the C 3 -C 10  cycloalkenyl group. 
     The term “C 1 -C 10  heterocycloalkenyl group” as used herein refers to a monovalent monocyclic group that has at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, 1 to 10 carbon atoms, and at least one carbon-carbon double bond in its ring. Non-limiting examples of the C 1 -C 10  heterocycloalkenyl group include a 4,5-dihydro-1,2,3,4-oxatriazolyl group, a 2,3-dihydrofuranyl group, and a 2,3-dihydrothiophenyl group. The term “C 1 -C 10  heterocycloalkenylene group” as used herein refers to a divalent group having the same structure as the C 1 -C 10  heterocycloalkenyl group. 
     The term “C 6 -C 60  aryl group” as used herein refers to a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms, and a C 6 -C 60  arylene group used herein refers to a divalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. Non-limiting examples of the C 6 -C 60  aryl group include a phenyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, and a chrysenyl group. When the C 6 -C 60  aryl group and the C 6 -C 60  arylene group each include two or more rings, the rings may be fused to each other. 
     The term “C 1 -C 60  heteroaryl group” as used herein refers to a monovalent group having a carbocyclic aromatic system that has at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, in addition to 1 to 60 carbon atoms. The term “C 1 -C 60  heteroarylene group” as used herein refers to a divalent group having a carbocyclic aromatic system that has at least one heteroatom selected from N, O, Si, P, and S as a ring-forming atom, in addition to 1 to 60 carbon atoms. Non-limiting examples of the C 1 -C 60  heteroaryl group include a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, and an isoquinolinyl group. When the C 1 -C 60  heteroaryl group and the C 1 -C 60  heteroarylene group each include two or more rings, the rings may be condensed with each other. 
     The term “C 6 -C 60  aryloxy group” as used herein refers to —OA 102  (wherein A 102  is the C 6 -C 60  aryl group), and a C 6 -C 60  arylthio group used herein indicates —SA 103  (wherein A 103  is the C 6 -C 60  aryl group). 
     The term “monovalent non-aromatic condensed polycyclic group” as used herein refers to a monovalent group (for example, having 8 to 60 carbon atoms) having two or more rings condensed with each other, only carbon atoms as ring-forming atoms, and no aromaticity in its entire molecular structure. A detailed example of the monovalent non-aromatic condensed polycyclic group is a fluorenyl group. The term “divalent non-aromatic condensed polycyclic group” as used herein refers to a divalent group having the same structure as the monovalent non-aromatic condensed polycyclic group. 
     The term “monovalent non-aromatic condensed heteropolycyclic group” as used herein refers to a monovalent group (for example, having 1 to 60 carbon atoms) having two or more rings condensed to each other, at least one heteroatom selected from N, O, Si, P, and S, other than carbon atoms, as a ring-forming atom, and no aromaticity in its entire molecular structure. An example of the monovalent non-aromatic condensed heteropolycyclic group is a carbazolyl group. The term “divalent non-aromatic condensed heteropolycyclic group” as used herein refers to a divalent group having the same structure as the monovalent non-aromatic condensed heteropolycyclic group. 
     The term “C 5 -C 60  carbocyclic group” as used herein refers to a monocyclic or polycyclic group having 5 to 60 carbon atoms in which a ring-forming atom is a carbon atom only. The term “C 5 -C 60  carbocyclic group” as used herein refers to an aromatic carbocyclic group or a non-aromatic carbocyclic group. The C 5 -C 60  carbocyclic group may be a ring, such as benzene, a monovalent group, such as a phenyl group, or a divalent group, such as a phenylene group. In one or more embodiments, depending on the number of substituents connected to the C 5 -C 60  carbocyclic group, the C 5 -C 60  carbocyclic group may be a trivalent group or a quadrivalent group. 
     The term “C 1 -C 60  heterocyclic group” as used herein refers to a group having the same structure as the C 5 -C 60  carbocyclic group, except that as a ring-forming atom, at least one heteroatom selected from N, O, Si, P, and S is used in addition to carbon (the number of carbon atoms may be in a range of 1 to 60). 
     In the present specification, at least one substituent of the substituted C 5 -C 60  carbocyclic group, the substituted C 1 -C 60  heterocyclic group, the substituted C 3 -C 10  cycloalkylene group, the substituted C 1 -C 10  heterocycloalkylene group, the substituted C 3 -C 10  cycloalkenylene group, the substituted C 1 -C 10  heterocycloalkenylene group, the substituted C 6 -C 60  arylene group, the substituted C 1 -C 60  heteroarylene group, the substituted divalent non-aromatic condensed polycyclic group, the substituted divalent non-aromatic condensed heteropolycyclic group, the substituted C 1 -C 60  alkyl group, the substituted C 2 -C 60  alkenyl group, the substituted C 2 -C 60  alkynyl group, the substituted C 1 -C 60  alkoxy group, the substituted C 3 -C 10  cycloalkyl group, the substituted C 1 -C 10  heterocycloalkyl group, the substituted C 3 -C 10  cycloalkenyl group, the substituted C 1 -C 10  heterocycloalkenyl group, the substituted C 6 -C 60  aryl group, the substituted C 6 -C 60  aryloxy group, the substituted C 6 -C 60  arylthio group, the substituted C 1 -C 60  heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group may be selected from: 
     deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, and a C 1 -C 60  alkoxy group; 
     a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, and a C 1 -C 60  alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), and —P(═O)(Q 11 )(Q 12 ); 
     a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group; 
     a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, a C 1 -C 60  alkoxy group, a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 6 -C 60  aryloxy group, a C 6 -C 60  arylthio group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), and —P(═O)(Q 21 )(Q 22 ); and 
     —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ), and 
     Q 11  to Q 13 , Q 21  to Q 23 , and Q 31  to Q 33  may each independently be selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60  alkyl group, a C 2 -C 60  alkenyl group, a C 2 -C 60  alkynyl group, a C 1 -C 60  alkoxy group, a C 3 -C 10  cycloalkyl group, a C 1 -C 10  heterocycloalkyl group, a C 3 -C 10  cycloalkenyl group, a C 1 -C 10  heterocycloalkenyl group, a C 6 -C 60  aryl group, a C 1 -C 60  heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group. 
     The term “Ph” as used herein refers to a phenyl group, the term “Me” as used herein refers to a methyl group, the term “Et” as used herein refers to an ethyl group, the term “ter-Bu” or “Bu t ” as used herein refers to a tert-butyl group, and the term “OMe” as used herein refers to a methoxy group. 
     The term “biphenyl group” as used herein refers to “a phenyl group substituted with a phenyl group”. In other words, the “biphenyl group” is a substituted phenyl group having a C 6 -C 60  aryl group as a substituent. 
     The term “terphenyl group” as used herein refers to “a phenyl group substituted with a biphenyl group”. In other words, the “terphenyl group” is a phenyl group having, as a substituent, a C 6 -C 60  aryl group substituted with a C 6 -C 60  aryl group. 
     * and *′ used herein, unless defined otherwise, each refer to a binding site to a neighboring atom in a corresponding formula. 
     Hereinafter, a compound according to embodiments and an organic light-emitting device according to embodiments will be described in detail with reference to Synthesis Examples and Examples. The wording “B was used instead of A” used in describing Synthesis Examples refers to that an identical molar equivalent of B was used in place of A. 
     EXAMPLE 
     Synthesis Example 1: Synthesis of Compound 1 
     
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 1-1 
     2-bromo-1,3-difluorobenzene (CAS=64248-56-2) reacted with carbazole in a Pd catalyst condition to obtain Intermediate 1-1. Intermediate 1-1 was identified by LC-MS. 
     C 30 H 19 BrN 2 : M+1 487.11. 
     (2) Synthesis of Compound 1 
     3.2 g of 3-(triphenylsilyl)phenylboronic acid, 4 g of Intermediate 1-1, 0.38 g of tetrakis(triphenylphosphine)palladium, and 2.8 g of potassium carbonate were added to a reaction container, dissolved in 40 mL of toluene, 10 mL of ethanol, and 10 mL of distilled water, and then refluxed for 24 hours. After the reaction was completed, the reaction solution was extracted therefrom by using ethyl acetate. An organic layer collected therefrom was dried by using magnesium sulfate, and a residue obtained by evaporating a solvent therefrom was separated and purified by silica gel column chromatography to obtain 3.3 g (yield: 55%) of Compound 1. Compound 1 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 2: Synthesis of Compound 2 
     
       
         
         
             
             
         
       
     
     4.2 g (yield: 80%) of Compound 2 was synthesized in the same manner as in Synthesis of Compound 1, except that (3-(9H-carbazol-9-yl)phenyl)boronic acid was used instead of 3-(triphenylsilyl)phenylboronic acid. Compound 2 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 3: Synthesis of Compound 3 
     
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 3-1 
     1-bromo-3,5-difluorobenzene (CAS=461-96-1) reacted with carbazole in a Pd catalyst condition to obtain Intermediate 3-1. Intermediate 3-1 was identified by LC-MS. 
     C 30 H 19 BrN 2 : M+1 487.11. 
     (2) Synthesis of Compound 3 
     4.4 g (yield: 83%) of Compound 3 was synthesized in the same manner as in Synthesis of Compound 2, except that Intermediate 3-1 was used instead of Intermediate 1-1, and (2-(9H-carbazol-9-yl)phenyl)boronic acid was used instead of (3-(9H-carbazol-9-yl)phenyl)boronic acid. Compound 3 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 4: Synthesis of Compound 8 
     
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 8-1 
     1,2-dibromobenzene (CAS=583-53-9) reacted with n-BuLi and then reacted with chlorotriphenylsilane (CAS=76-86-8) to obtain Intermediate 8-1. Intermediate 8-1 was identified by LC-MS. 
     C 24 H 19 BrSi: M+1 415.11. 
     (2) Synthesis of Intermediate 8-2 
     Intermediate 8-1 reacted with n-BuLi and then reacted with trimethyl borate to obtain Intermediate 8-2. Intermediate 8-2 was identified by LC-MS. 
     C 24 H 21 BO 2 Si: M+1 381.25. 
     (3) Synthesis of Intermediate 8-3 
     1-bromo-3,5-difluorobenzene (CAS=461-96-1) reacted with 9,9-dimethyl-9,10-dihydroacridine (CAS=6267-02-3) in a Pd catalyst condition to obtain Intermediate 8-3. Intermediate 8-3 was identified by LC-MS. 
     C 36 H 31 BrN 2 : M+1 571.25. 
     (4) Synthesis of Compound 8 
     2.9 g of Intermediate 8-2, 4.3 g of Intermediate 8-3, 0.35 g of tetrakis(triphenylphosphine)palladium, 2.6 g of potassium carbonate were added to a reaction container, dissolved in 40 mL of toluene, 10 mL of ethanol, and 10 mL of distilled water, and then refluxed for 24 hours. After the reaction was completed, the reaction solution was extracted therefrom by using ethyl acetate. An organic layer collected therefrom was dried by using magnesium sulfate, and a residue obtained by evaporating a solvent therefrom was separated and purified by silica gel column chromatography to obtain 3.4 g (yield: 53%) of Compound 8. Compound 8 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 5: Synthesis of Compound 13 
     
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 13-1 
     1,2-dibromobenzene (CAS=583-53-9) reacted with dibenzothiophene-1-boronic acid (CAS=1245943-60-5) in a Pd catalyst condition to obtain Intermediate 13-1. Intermediate 13-1 was identified by LC-MS. 
     C 18 H 11 BrS: M+1 338.87. 
     (2) Synthesis of Intermediate 13-2 
     Intermediate 13-1 reacted with n-BuLi and then reacted with trimethyl borate to obtain Intermediate 13-2. Intermediate 13-2 was identified by LC-MS. 
     C 18 H 13 BO 2 S: M+1 305.1. 
     (3) Synthesis of Intermediate 13-3 
     2-bromo-1,4-difluorobenzene (CAS=399-94-0) reacted with 10H-phenoxazine (CAS=135-67-1) in a Pd catalyst condition to obtain Intermediate 13-3. Intermediate 13-3 was identified by LC-MS. 
     C 30 H 19 BrN 2 O 2 : M+1 519.13. 
     (4) Synthesis of Compound 13 
     4.5 g of Intermediate 13-2, 2.6 g of Intermediate 13-3, 0.4 g of tetrakis(triphenylphosphine)palladium, 3 g of potassium carbonate were added to a reaction container, dissolved in 40 mL of toluene, 10 mL of ethanol, and 10 mL of distilled water, and then refluxed for 24 hours. After the reaction was completed, the reaction solution was extracted therefrom by using ethyl acetate. An organic layer collected therefrom was dried by using magnesium sulfate, and a residue obtained by evaporating a solvent therefrom was separated and purified by silica gel column chromatography to obtain 4.2 g (yield: 70%) of Compound 13. Compound 13 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 6: Synthesis of Compound 16 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 16-1 
     1-bromo-3-fluorobenzene (CAS=1073-06-9) reacted with 3,9′-bicarbazole (CAS=18628-07-4) in a Pd catalyst condition to obtain Intermediate 16-1. Intermediate 16-1 was identified by LC-MS. 
     C 30 H 19 BrN 2 : M+1 486.11. 
     (2) Synthesis of Intermediate 16-2 
     Intermediate 16-1 reacted with n-BuLi and then reacted with trimethyl borate to obtain Intermediate 16-2. Intermediate 16-2 was identified by LC-MS. 
     C 30 H 21 BN 2 O 2 : M+1 453.24. 
     (3) Synthesis of Compound 16 
     5 g of Intermediate 1-1, 4.7 g of Intermediate 16-2, 0.47 g of tetrakis(triphenylphosphine)palladium, and 3.5 g of potassium carbonate were added to a reaction container, dissolved in 60 mL of toluene, 15 mL of ethanol, and 15 mL of distilled water, and then refluxed for 24 hours. After the reaction was completed, the reaction solution was extracted therefrom by using ethyl acetate. An organic layer collected therefrom was dried by using magnesium sulfate, and a residue obtained by evaporating a solvent therefrom was separated and purified by silica gel column chromatography to obtain 5.3 g (yield: 63%) of Compound 16. Compound 16 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 7: Synthesis of Compound 21 
     
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 21-1 
     2-bromo-1,4-difluorobenzene (CAS=399-94-0) reacted with carbazole in a Pd catalyst condition to obtain Intermediate 21-1. Intermediate 21-1 was identified by LC-MS. 
     C 30 H 19 BrN 2 : M+1 487.11. 
     (2) Synthesis of Intermediate 21-2 
     Intermediate 21-2 was synthesized in the same manner as in Synthesis of Intermediate 13-2, except that dibenzofuran-1-boronic acid was used instead of dibenzothiophene-1-boronic acid. Intermediate 21-2 was identified by LC-MS. 
     C 18 H 13 BO 3 : M+1 289.25. 
     (3) Synthesis of Compound 21 
     4.7 g of Intermediate 21-1, 2.9 g of Intermediate 21-2, 0.45 g of tetrakis(triphenylphosphine)palladium, and 3.3 g of potassium carbonate were added to a reaction container, dissolved in 50 mL of toluene, 12 mL of ethanol, and 12 mL of distilled water, and then refluxed for 24 hours. After the reaction was completed, the reaction solution was extracted therefrom by using ethyl acetate. An organic layer collected therefrom was dried by using magnesium sulfate, and a residue obtained by evaporating a solvent therefrom was separated and purified by silica gel column chromatography to obtain 4.7 g (yield: 75%) of Compound 21. Compound 21 was identified by LC-MS and  1 H-NMR. 
     Synthesis Example 8: Synthesis of Compound 30 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     (1) Synthesis of Intermediate 30-1 
     3,6-bis(1,1-dimethylethyl)-9H-carbazole (CAS=37500-95-1) reacted with 1-bromo-2-fluorobenzene (CAS=1072-85-1) in a Pd catalyst condition to obtain Intermediate 30-1. Intermediate 30-1 was identified by LC-MS. 
     C 26 H 28 BrN: M+1 434.27. 
     (2) Synthesis of Intermediate 30-2 
     Intermediate 30-1 reacted with n-BuLi and then reacted with trimethyl borate to obtain Intermediate 30-2. Intermediate 30-2 was identified by LC-MS. 
     C 26 H 30 BNO 2 : M+1 400.43. 
     (3) Synthesis of Compound 30 
     5 g of Intermediate 3-1, 4 g of Intermediate 30-2, 0.47 g of tetrakis(triphenylphosphine)palladium, and 3.5 g of potassium carbonate were added to a reaction container, dissolved in 60 mL of toluene, 15 mL of ethanol, and 15 mL of distilled water, and then refluxed for 24 hours. After the reaction was completed, the reaction solution was extracted therefrom by using ethyl acetate. An organic layer collected therefrom was dried by using magnesium sulfate, and a residue obtained by evaporating a solvent therefrom was separated and purified by silica gel column chromatography to obtain 5.63 g (yield: 72%) of Compound 30. Compound 30 was identified by LC-MS and  1 H-NMR. 
       1 H NMR and LC-MS of Compounds synthesized in Synthesis Examples are shown in Table 1. 
     Synthesis methods of compounds other than Compounds shown in Table 1 may also be easily recognized by those of ordinary skill in the art by referring to the synthesis mechanisms and source materials described above. 
     
       
         
           
               
               
               
             
               
                 TABLE 1 
               
             
            
               
                   
               
               
                   
                   
                 LC-MS 
               
            
           
           
               
               
               
               
            
               
                 Com- 
                   
                 Found 
                   
               
               
                 pound 
                   1 H NMR (CDCl 3 , 400 MHz) 
                 [M + 1] 
                 calc. 
               
               
                   
               
               
                 1 
                 8.14-8.12 (4H, m), 7.67-7.64 (6H, m), 7.59-7.55  
                 743.25 
                 742.28 
               
               
                   
                 (2H, m), 7.42-7.38 (4H, m), 7.31-7.14 (22H, m) 
                   
                   
               
               
                 2 
                 8.14-8.10 (6H, m), 7.53 (1H, t), 7.42-7.38  
                 650.29 
                 649.25 
               
               
                   
                 (4H, m), 7.36-7.19 (18H, m), 6.74 (1H, s),  
                   
                   
               
               
                   
                 6.72 (1H, s) 
                   
                   
               
               
                 3 
                 8.12-8.10 (6H, m), 7.74 (1H, t),  
                 650.28 
                 649.25 
               
               
                   
                 7.62-7.59 (1H, m), 7.39-7.28 (21H, m),  
                   
                   
               
               
                   
                 7.08-7.05 (1H, m), 6.65 (1H, t) 
                   
                   
               
               
                 8 
                 7.63-7.61 (7H, m), 7.52-7.42 (5H, m), 7.31-7.23  
                 827.18 
                 826.37 
               
               
                   
                 (11H, m), 7.00-6.83 (8H, m), 6.59 (2H, d), 5.97  
                   
                   
               
               
                   
                 (1H, t), 1.76-1.75 (6H, m), 1.67-1.65 (6H, m) 
                   
                   
               
               
                 13 
                 8.19-8.17 (1H, m), 8.07 (1H, d), 7.99 (1H, d),  
                 699.26 
                 698.20 
               
               
                   
                 7.85 (1H, t), 7.62-7.39 (7H, m),  
                   
                   
               
               
                   
                 6.92-6.90 (2H, d), 6.83-6.75 (12H, m), 
                   
                   
               
               
                   
                 6.62 (1H, m), 6.54-6.52 (4H, m) 
                   
                   
               
               
                 16 
                 8.39-8.36 (1H, m), 8.14-8.10 (6H, m), 7.95  
                 815.40 
                 814.31 
               
               
                   
                 (1H, m), 7.53-7.50 (2H, m), 7.40-7.19  
                   
                   
               
               
                   
                 (26H, m), 6.74 (1H, s), 6.72 (1H, s) 
                   
                   
               
               
                 21 
                 8.26-8.25 (1H, m), 8.14-8.10(4H, m), 7.95-7.92 
                 651.21 
                 650.24 
               
               
                   
                 (1H, m), 7.70-7.65 (5H, m), 7.53-7.27  
                   
                   
               
               
                   
                 (17H, m), 7.10 (1H, d), 6.32 (1H, d) 
                   
                   
               
               
                 30 
                 8.13-8.11 (4H, m), 8.06 (2H, d), 7.39-7.18  
                 762.43 
                 761.38 
               
               
                   
                 (21H, m), 7.06 (1H, t), 6.92 (1H, d), 
                   
                   
               
               
                   
                 1.39 (18H, s) 
               
               
                   
               
            
           
         
       
     
     Example 1 
     As an anode, A Corning 15 Ω/cm 2  (1,200 Å) ITO glass substrate was cut to a size of 50 mm×50 mm×0.7 mm, sonicated with isopropyl alcohol and pure water each for 5 minutes, and then cleaned by exposure to ultraviolet rays and ozone for 30 minutes. Then, the ITO glass substrate was provided to a vacuum deposition apparatus. NPD was vacuum-deposited on the ITO glass substrate to form a hole injection layer having a thickness of 300 Å, and a hole transport compound TCTA was vacuum-deposited on the hole injection layer to form a first hole transport layer having a thickness of 200 Å. A hole transport compound CzSi was vacuum-deposited on the first hole transport layer to form a second hole transport layer having a thickness of 100 Å. Compound 1 (host) and Ir(pmp) 3  (dopant) were co-deposited on the second hole transport layer at a weight ratio of 92:8 to form an emission layer having a thickness of 250 Å. Then, an electron transport compound TSPO1 was deposited to form a buffer layer having a thickness of 200 Å, and an electron transport compound TPBI was deposited to form an electron transport layer having a thickness of 300 Å. LiF, which is an alkali metal halide, was deposited on the electron transport layer to form an electron injection layer having a thickness of 10 Å, and Al was vacuum-deposited to form a cathode electrode having a thickness of 3,000 Å, thereby forming a LiF/Al electrode. In this manner, an organic light-emitting device was manufactured. 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     Examples 2 to 8 
     Organic light-emitting devices were manufactured in the same manner as in Example 1, except that Compounds shown in Table 2 were each used instead of Compound 1 in forming an emission layer. 
     Comparative Examples 1 to 4 
     Organic light-emitting devices were manufactured in the same manner as in Example 1, except that mCP and Compounds A, B, and C were each used instead of Compound 1 in forming an emission layer. 
     
       
         
         
             
             
         
       
     
     Evaluation Example 
     The device performances (driving voltage, maximum quantum efficiency, and emission color) of the organic light-emitting devices manufactured according to Examples 1 to 8 and Comparative Examples 1 to 4 when driven at a current density of 2.3 mA/cm 2  were measured, and results thereof are shown in Table 2.
         Luminance: Power was supplied by using a current-voltage meter (Keithley SMU 236), and luminance was measured by using a luminance meter PR650.   Efficiency: Power was supplied by using a current-voltage meter (Keithley SMU 236), and efficiency was measured by using a luminance meter PR650.       

     
       
         
           
               
               
               
               
               
               
             
               
                 TABLE 2 
               
               
                   
               
               
                   
                   
                   
                   
                 Maximum 
                   
               
               
                   
                 Host in 
                 Driving 
                 Current 
                 quantum 
                   
               
               
                   
                 emission 
                 voltage 
                 density 
                 efficiency 
                 Emission 
               
               
                   
                 layer 
                 (V) 
                 (mA/cm 2 ) 
                 (%) 
                 color 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 Example 1 
                 Compound 1 
                 4.3 
                 2.3 
                 14.8 
                 blue 
               
               
                 Example 2 
                 Compound 2 
                 4.1 
                 2.3 
                 15.9 
                 blue 
               
               
                 Example 3 
                 Compound 3 
                 4.1 
                 2.3 
                 15.7 
                 blue 
               
               
                 Example 4 
                 Compound 8 
                 4.6 
                 2.3 
                 11.8 
                 blue 
               
               
                 Example 5 
                 Compound 13 
                 4.2 
                 2.3 
                 13.5 
                 blue 
               
               
                 Example 6 
                 Compound 16 
                 3.9 
                 2.3 
                 16.2 
                 blue 
               
               
                 Example 7 
                 Compound 21 
                 4.2 
                 2.3 
                 14.7 
                 blue 
               
               
                 Example 8 
                 Compound 30 
                 4.3 
                 2.3 
                 12.6 
                 blue 
               
               
                 Comparative 
                 mCBP 
                 4.4 
                 2.3 
                 12.1 
                 blue 
               
               
                 Example 1 
                   
                   
                   
                   
                   
               
               
                 Comparative 
                 Compound A 
                 4.2 
                 2.3 
                 14.0 
                 blue 
               
               
                 Example 2 
                   
                   
                   
                   
                   
               
               
                 Comparative 
                 Compound B 
                 4.3 
                 2.3 
                 12.5 
                 blue 
               
               
                 Example 3 
                   
                   
                   
                   
                   
               
               
                 Comparative 
                 Compound C 
                 5.1 
                 2.3 
                 13.3 
                 blue 
               
               
                 Example 4 
                   
                   
                   
                   
                   
               
               
                   
               
            
           
         
       
     
     From Table 2, it is confirmed that the organic light-emitting devices of Examples 1 to 8, in which the compounds according to one or more embodiments are used in the emission layer, have driving voltages lower than or equal to those of the organic light-emitting devices of Comparative Examples 1 to 4. In addition, most of the organic light-emitting devices of Examples 1 to 8 exhibited improved maximum quantum efficiency. 
     That is, when the compounds according to one or more embodiments are used as the material for forming the emission layer of the organic light-emitting device, the compounds have an improved driving voltage and efficiency, and thus, may be suitable for blue light emission. 
     The heterocyclic compound may have high triplet energy, and the organic light-emitting device including the heterocyclic compound may have a low driving voltage, high efficiency, a long lifespan, and high maximum quantum efficiency. 
     It should be understood that embodiments described herein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments. 
     While one or more embodiments have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope as defined by the following claims.